Treatment of allograft renal cell carcinoma with partial nephrectomy in a pediatric kidney transplant.
Case report
Pediatric transplant
Renal allograft
Renal cell carcinoma
de novo RCC
Journal
Journal of pediatric surgery case reports
ISSN: 2213-5766
Titre abrégé: J Pediatr Surg Case Rep
Pays: Netherlands
ID NLM: 101628383
Informations de publication
Date de publication:
Oct 2021
Oct 2021
Historique:
entrez:
7
1
2022
pubmed:
8
1
2022
medline:
8
1
2022
Statut:
ppublish
Résumé
Renal cell carcinoma (RCC) is a common malignancy among kidney transplant recipients that often occurs in the native kidney. The incidence of RCC in the renal allograft is rare and carries the double risk of returning to dialysis and the development of metastatic cancer. The majority of reported cases of RCC in transplanted kidneys are in adult recipients and its occurrence in the pediatric age group is an uncommon event. There are currently no established guidelines on the treatment of RCC in transplant recipients. We report our experience of a 15-year-old male who developed allograft RCC 12 years later after transplantation. MRI confirmed the presence of the mass near the hilum of the renal allograft and biopsy revealed a Papillary Renal Cell Carcinoma (PRCC) type I. A partial allograft nephrectomy was successfully performed with negative tumor margins. The patient's serum creatinine 12 months post-operation was 1.9 mg/dL and presently he has no evidence of residual disease, recurrence, or metastasis. Partial nephrectomy is an effective treatment option for renal allograft RCC as it spares the patient from returning to dialysis until retransplantation is possible and necessary.
Identifiants
pubmed: 34993052
doi: 10.1016/j.epsc.2021.102018
pmc: PMC8730291
mid: NIHMS1766754
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : NIDDK NIH HHS
ID : T35 DK121678
Pays : United States
Déclaration de conflit d'intérêts
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Références
J Urol. 2013 Aug;190(2):407-16
pubmed: 23665399
Clin Transplant. 2013 Mar-Apr;27(2):E199-205
pubmed: 23419131
Am J Nephrol. 2013;37(2):91-6
pubmed: 23363786
Actas Urol Esp. 2013 Apr;37(4):242-8
pubmed: 23246102
Transplantation. 2000 Dec 15;70(11):1650-6
pubmed: 11152228
Urol Int. 2001;67(1):24-7
pubmed: 11464111
Urology. 2007 Apr;69(4):778.e5-7
pubmed: 17445675
Transplant Rev (Orlando). 2016 Jan;30(1):20-6
pubmed: 26318289
Urol Ann. 2018 Apr-Jun;10(2):229-232
pubmed: 29719341
Transl Androl Urol. 2020 Dec;9(6):3149-3159
pubmed: 33457287
Transplantation. 1995 Feb 27;59(4):480-5
pubmed: 7878750
Transplantation. 2020 Apr;104(4S1 Suppl 1):S11-S103
pubmed: 32301874
Urology. 2007 Mar;69(3):462-4
pubmed: 17382145
Clin Transpl. 1998;:147-58
pubmed: 10503093
Pediatr Transplant. 2020 Feb;24(1):e13614
pubmed: 31709694
Transplantation. 2001 Aug 15;72(3):540-1
pubmed: 11502993
Cancer. 2006 Dec 15;107(12):2906-14
pubmed: 17109448
Transplantation. 2005 Oct 15;80(7):883-9
pubmed: 16249734
Am J Transplant. 2012 Dec;12(12):3308-15
pubmed: 22959020
Radiology. 2011 Sep;260(3):900-7
pubmed: 21771957
Adv Ren Replace Ther. 2000 Apr;7(2):147-56
pubmed: 10782732
World J Clin Cases. 2021 Jun 16;9(17):4365-4372
pubmed: 34141802
Int J Urol. 1997 Nov;4(6):611-4
pubmed: 9477194